Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: GENSCRIPT USA INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-12-12 to 2024-02-11
Current total value of award: $17391
Description: LARGE SCALE PRODUCTION RUN OF RECOMBINANT, CHIMERIC ANTI-RICKETTSIA MONOCLONAL ANTIBODIES (AMBIS #2202209)